Dr. Anthony B. Morlandt, Assistant Professor Department of Oral and Maxillofacial Surgery of the University of Alabama at Birmingham, joins Proteocyte AI’s Clinical Advisory Board

Proteocyte AI, a company designing tests that predict the progression of premalignant lesions, announced today that Dr. Anthony B. Morlandt, Assistant Professor, Chief Oral Oncology, Department of Oral and Maxillofacial Surgery, University of Alabama at Birmingham,...

Today Proteocyte Diagnostics becomes…

  Proteocyte Diagnostics, a computational pathology company that has built a platform-based technology that predicts your risk of developing cancer, announced a name change to Proteocyte AI, effectively immediately. “Our new corporate identity better reflects how...